Aurobindo Pharma soars on reporting 91% rise in Q3 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Aurobindo Pharma is currently trading at Rs. 1012.95, up by 10.95 points or 1.09% from its previous closing of Rs. 1002.00 on the BSE.
The scrip opened at Rs. 1038.75 and has touched a high and low of Rs. 1038.75 and Rs. 1000.20 respectively. So far 209328 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1177.00 on 30-Jan-2024 and a 52 week low of Rs. 443.15 on 14-Mar-2023.
Last one week high and low of the scrip stood at Rs. 1074.00 and Rs. 977.25 respectively. The current market cap of the company is Rs. 59197.38 crore.
The promoters holding in the company stood at 51.83%, while Institutions and Non-Institutions held 41.32% and 6.85% respectively.
Aurobindo Pharma has reported over 2-fold jump in its net profit at Rs 623.78 crore for the third quarter ended December 31, 2023 (Q3FY24) as compared to Rs 298.82 crore for the same quarter in the previous year. Total income of the company increased by 23.95% at Rs 3023.16 crore for Q3FY24 as compared Rs 2438.92 crore for corresponding quarter of the previous year.
On consolidated basis, the company has reported 91.44% rise in net profit at Rs 939.97 crore for Q3FY24 as compared to Rs 491.01 crore for the same quarter in the previous year. Total income of the company increased by 15.61% at Rs 7514.30 crore for Q3FY24 as compared Rs 6499.78 crore for corresponding quarter of the previous year.
